Thornhill Medical
Lesley Gouldie has a diverse work experience spanning over two decades. From 1997 to 1998, they worked at IBM Canada Ltd. as the Manager of Finance & Operations, where they developed annual strategies, budgets, and key performance indicators. In 1998, they joined Thomson Reuters (Nelson Education)) as the Chief Financial Officer and Senior Vice President, where they successfully doubled the operating income as a percentage of sales and quadrupled the operating income in absolute dollars over a six-year period. Lesley also drove revenue growth of 26.5% through strategic acquisitions. In 2008, Lesley became the Chief Executive Officer of yconic, a position they held until 2012. During their tenure, they led the company with a strong vision and contributed to its growth. In 2012, they joined Meditech International Inc. as the COO, providing strategic leadership until 2015. Since 2015, Lesley has been the President and CEO of Thornhill Medical. Their expertise in business development and financial management has been instrumental in driving the company's success.
Lesley Gouldie has a diverse education history. Lesley completed a Queens Executive Leadership Program at Queen's University, focusing on executive leadership skills. Additionally, Lesley completed a Logistics Management Course at the Schulich School of Business - York University.
Prior to these programs, Lesley studied at the University of the Witwatersrand, where they obtained a B.Com and B.Acc degree. Their field of study during this time was focused on becoming a Chartered Accountant.
In terms of certifications, Lesley holds a CPA, CA (Chartered Professional Accountant) designation and a CA (SA) (Chartered Accountant South Africa) designation. However, specific details regarding the institution and the year of obtaining these certifications are not provided.
Thornhill Medical
Briefly, what does your company do?*Thornhill, an innovative SME is the inventor, developer and supplier of novel and valuable healthcare systems and devices important in emergency, mobile, and remote/austere health delivery sectors. This includes EMS, Humanitarian, Public Safety and Military and other “challenging circumstance” applications.Thornhill is internationally recognized as a leader in the precise control and management of arterial blood gases. This expertise has allowed it to develop and supply a range of novel, IP protected, portable, medical systems that are able to provide critical life support functions to those deployed in challenging circumstances. Thornhill Medical delivers unique and valuable solutions that include 1) MOVES® SLC™: a portable life support for casualty care during patient transport, in field hospitals and forward surgical suites; 2) ClearMateTM: immediate and effective treatment for carbon monoxide poisoning; 3) MADMTM: mobile anesthesia; and 4) RespirAct™ RA-MR: an investigational tool used in diagnostic procedures which measure vascular reactivity.Thornhill differentiates itself in this market via its superior understanding of the utilization of arterial blood gases, thus eliminating, or substantially reducing the bulk, weight, cost and logistic burdens of other products, while optimizing patient outcomes. The efficacy of its solutions is recognized globally, with the United States Marine Corps, the Government of Ontario and the Federal Government of Canada being notable customers.